Artificial intelligence and biomarkers take centre stage at a new IGTP-EATRIS event

Tuesday, 20 October 2026 - Campus Can Ruti, Conferences, Institutional

This morning, the Germans Trias i Pujol Research Institute (IGTP) held a new event in collaboration with EATRIS, the European infrastructure for translational medicine, focusing this year on the role of artificial intelligence in biomarker research and precision medicine.

Entitled EATRIS, Artificial Intelligence, and Biomarkers in Biomedical Research, the event brought together researchers and healthcare professionals from the Can Ruti Campus and other institutions to share knowledge, experiences and opportunities for collaboration in this rapidly evolving field.

Jordi Barretina, Director of IGTP, opened the event with an institutional welcome. This was followed by the first session, focusing on the role of EATRIS in European translational research, with contributions from David Velasco Gail, National Coordinator of EATRIS Spain at the Carlos III Health Institute (ISCIII); David Morrow, Scientific Director of Advanced Therapies at EATRIS, who participated online; and Julia García-Prado, Scientific Director of IGTP and member of the ISCIII-EATRIS Advisory Board. The session highlighted the role of this infrastructure in translational biomedical research and the opportunities it offers to the research community.

The scientific focus of the session was provided by Alain Van Gool, Chair of the EATRIS Biomarker Platform, member of the EATRIS Digital Biomarkers Working Group and researcher at Radboud UMC, who explored the potential of artificial intelligence in biomarker research.

The event also featured a panel discussion with Victoria Delgado, Scientific Director of CMCiB; Gemma Monté-Rubio, neuroscientist and Head of the Bioimaging Unit at CMCiB; and Sílvia Bonàs-Guarch, researcher on the GCAT project. The discussion provided an opportunity to share challenges, experiences and perspectives on the application of artificial intelligence and biomarkers in biomedical and clinical research.

Josep Maria Torras, from the IGTP Innovation and Business Development Unit, presented the Health Technology Assessment (HTA) service and its collaborative work with the EATRIS Expert Centres, highlighting the resources available to support the translation of research findings into clinical practice.

This event builds on the ongoing collaboration between IGTP and EATRIS. The previous edition, held in 2024, focused on patient involvement in translational research, further strengthening the links between the Institute and the European infrastructure.

Julia García-Prado, Scientific Director of IGTP, welcomed the event and highlighted the importance of bringing together the research community, European research infrastructures and teams working on new digital tools and biomarkers to advance translational research.